• Home
  • Contact Us
  • Try it!
  • Blog
  • Vizit Graphs

Follow us

Recent Posts

  • Biovista in World’s Top 20 AI Drug Development Companies March 22, 2019
  • Biovista signs EU-IMI2 research agreement to advance neurotoxicity de-risking in preclinical drug discovery March 15, 2019
  • The increasing importance of predicting AEs & the role of Augmented Intelligence September 10, 2018
  • New Vizit Bibliography pane January 8, 2018
  • Share to Weibo added to Biovista Vizit October 25, 2017

Biovista Vizit

Biovista Vizit

  • Try it!
  • Blog
  • Vizit Graphs

NIVOLUMAB

Immune checkpoint blockade in cancer immunotherapy

August 28, 2018Cancer, Cancer Immunotherapy, Vizit Graphs
Immune checkpoint blockade in cancer immunotherapy

Explore immune checkpoint blockade (PD-1, CTLA-4) in cancer immunotherapy with Biovista Vizit. Explore the live graph.

Vizit Graphs Tag Cloud

APOPTOTIC PROCESS TH17 CELLS RHEUMATOID ARTHRITIS HELICOBACTER PYLORI ESCHERICHIA COLI CANDIDA ALBICANS FOXP3 AUTOPHAGY CELL DEATH CD4 INSULIN IL23A ALZHEIMER'S DISEASE CELL DIFFERENTIATION IMMUNE RESPONSE LISTERIA MONOCYTOGENES PORPHYROMONAS GINGIVALIS CTLA4 STAPHYLOCOCCUS AUREUS METFORMIN IL17A NEURODEGENERATIVE DISORDERS STREPTOCOCCUS PNEUMONIAE BREAST CANCER ANGIOGENESIS PARKINSON DISEASE SOD1 CASP3 IL6 PSEUDOMONAS AERUGINOSA REMICADE TNF CLOSTRIDIUM DIFFICILE CANCER ERBB-2 1-METHYL-4-PHENYL-1-2-3-6-TETRAHYDROPYRIDINE DOXORUBICIN RECEPTOR CELL PROLIFERATION IFNG DIABETES MELLITUS CELL DIVISION TP53 INFLAMMATION AGING

© 2019 Biovista Vizit All Rights Reserved.